Published in J Clin Oncol on January 02, 2013
Death in the Digital Age: A Systematic Review of Information and Communication Technologies in End-of-Life Care. J Palliat Med (2015) 0.84
Code status and resuscitation options in the electronic health record. Resuscitation (2014) 0.82
The role of palliative care in population management and accountable care organizations. J Palliat Med (2015) 0.79
Envisioning sophisticated electronic health records through the lens of health care reform. Am J Respir Crit Care Med (2013) 0.76
Advance care planning: ensuring that the patient's voice is heard. J Clin Oncol (2013) 0.75
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA (2008) 11.32
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol (2008) 9.43
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol (2011) 3.96
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. Cancer Discov (2011) 3.34
Cultural competence and health care disparities: key perspectives and trends. Health Aff (Millwood) (2005) 3.29
Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol (2011) 2.95
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol (2006) 2.80
Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol (2007) 2.77
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56
Resident physicians' use of professional and nonprofessional interpreters: a national survey. JAMA (2006) 2.55
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. J Clin Oncol (2006) 2.38
Resident physicians' preparedness to provide cross-cultural care. JAMA (2005) 2.36
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer. J Clin Oncol (2007) 2.33
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol (2004) 2.24
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23
Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg (2003) 2.22
Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med (2013) 2.20
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol (2005) 2.12
Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol (2011) 2.07
An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma. Hum Pathol (2012) 2.02
Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. J Clin Oncol (2009) 1.99
A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol (2010) 1.95
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
Caring for cancer survivors: a survey of primary care physicians. Cancer (2009) 1.92
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90
Using qualitative studies to improve the usability of an EMR. J Biomed Inform (2005) 1.90
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab. Neuro Oncol (2009) 1.83
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer (2014) 1.80
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors. Oncologist (2013) 1.79
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. J Mol Diagn (2007) 1.77
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist (2007) 1.75
HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol (2009) 1.74
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc (2007) 1.70
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma. Oncologist (2005) 1.68
Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin (2013) 1.62
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2011) 1.62
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers. Ann Thorac Surg (2013) 1.60
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59
Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing. Med Decis Making (2012) 1.57
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer (2007) 1.56
Cognitive-behavioral group treatment for disabling headache. Pain Med (2004) 1.54
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
Clinical effort against secondhand smoke exposure: development of framework and intervention. Pediatrics (2008) 1.51
Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res (2005) 1.49
Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics (2007) 1.48
Cancer knowledge, attitudes, beliefs, and practices (KABP) of disadvantaged women in the South Bronx. J Cancer Educ (2002) 1.47
Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care (2011) 1.47
Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care (2012) 1.46
Efficacy of telephone counseling for pregnant smokers: a randomized controlled trial. Obstet Gynecol (2006) 1.43
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol (2007) 1.42
Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol (2012) 1.42
Smoking among participants in the childhood cancer survivors cohort: the Partnership for Health Study. J Clin Oncol (2003) 1.42
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma. J Neurooncol (2008) 1.39
Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol (2008) 1.35
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro Oncol (2007) 1.34
Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer (2008) 1.33
Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women. Psychooncology (2006) 1.33
Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Med Care (2010) 1.31
Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol (2007) 1.30
Clozapine-induced eosinophilic colitis. Am J Psychiatry (2005) 1.27
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res (2010) 1.27
Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist (2008) 1.27
Cancer-related fatigue. J Natl Compr Canc Netw (2010) 1.26
Factors associated with identification and management of maternal depression by pediatricians. Pediatrics (2007) 1.25